Catégorie
Plerixafor
Numéro CAS
110078-46-1
Autre numéro CAS
155148-31-5(HCl Salt)
Formule moléculaire
C₂₈H₅₄N₈
Masse moléculaire
502.78 g/mol
Synonyme

1,1'-[1,4-Phenylenebis(methylene)]bis[1,4,8,11-tetraazacyclotetradecane]; 
1,4-Bis[(1,4,8,11-tetraazacyclotetradecan-1-yl)methyl]benzene; 1-[[4-(1,4,8,11-tetrazacyclotetradec-1-ylmethyl)phenyl]methyl]-1,4,8,11-tetrazacyclotetradecane

Mots-clés
Aromatics
Heterocycles
Enzyme inhibitors
Pharmaceutical Standards
Intermediates
Fine Chemicals
slide.1
Purity:

Above - 95.0%

Technical Data:

We will provide complete documentation support for every Standard Material. All analytical reports such as ¹H NMR, ¹³C NMR, Mass, FT-IR, HPLC Purity/GC Purity/QNMR Purity, Water content by KF/ Loss on Drying/TGA (Thermo-gravimetric Analysis). Certificate of Analysis with potency report. Each Standard Material SER (Structure Elucidation Report) with NMR, Mass, IR spectral interpretation. This whole analytical document can be included in eCTD, ANDA, DMF submissions to regulatory agencies.

Plerixafor standard refers to the reference form of plerixafor used for pharmaceutical quality control, research, and formulation purposes. It is a CXCR4 receptor antagonist that facilitates the mobilization of hematopoietic stem cells from the bone marrow into the bloodstream for collection prior to autologous stem cell transplantation. The standard ensures consistent purity, potency, and stability for accurate dosing and reliable clinical or laboratory use.